ON November 17, 2021 Nippon Kayaku reported that Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 (FY2022 1H) FY2022 : 1H (Press release, Nippon Kayaku, NOV 17, 2021, View Source [SID1234595723])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Topics (1) Net sales and income increase year-on-year; revised full-year business forecasts Net sales of 97%, operating income by industry segment of 107%, operating income of 111%, and profit attributable to owners of parent of 115% compared with forecasts for the first half of FY 2022 (announced on July 30, 2021)

・ Gross profit increased due to robust sales of Functional Chemicals business and others and cost reductions stemming from an increased capacity utilization rate
・ Although a 2Q impact was observed in the Safety Systems business and other areas due to a slowdown in automobile production affected by a semiconductor shortage, performance as a whole was solid in the first half
・ Profits increased due to controlled selling, general and administrative expenses. Acquisition of Treasury Stock (May to September)
・ 2.63 million shares (approx. 3.0bn yen)
・ 1.54% of the total number of issued shares excluding treasury stock Summary of Nippon Kayaku Group 5 FY2022 : 1H Topics

(2) Functional Chemicals Business Functional Materials
• Continued strong sales of semiconductor-related epoxy resins, such as for circuit boards and encapsulations
• In UV-curable resins, strong sales of materials for resists and display products
• Strong sales of cleaners for LCDs, semiconductors and electronic components Color Materials
• Continued strong demand for consumer inkjet printer colorants
• Good performance of industrial inkjet inks due to recoveries in printing demand and capital investment. Favorable sales of textile inkjet dyes due to market recovery

• Developers for thermal paper and dyes improved in the first half, but are still mid-recovery Catalyst
• Sales higher than expected due to orders received ahead of schedule Polatechno
• Optical Films business showed signs of recovery, particularly for automotive applications, but declined in 2Q under the impact of a decrease in production caused by a shortage of ICs
• Precision Components business is solid based on recovery in projector demand; X-ray analyzer components are strong 6 FY2022 : 1H Topics

(3) Pharmaceuticals Business
• Introduced ALAGLIOⓇ, a photodynamic diagnostics agent, acquired marketing rights, and commenced promotional activities
• PORTRAZZAⓇ, a new biomedicine for lung cancer treatment, achieved market penetration
• Biosimilars: INFLIXIMAB BS and TRASTUZUMAB BS grew
• Launched generic anti-cancer drug: PEMETREXED, metabolic malignancies
• Approved FOSAPREPITANT, antiemetic agent Safety Systems Business
• Decrease in sales stemming from a slowdown in automobile production in response to the worldwide semiconductor shortage
• Customer orders of local subsidiaries ceasing operations under lockdown in Malaysia have been covered within the Group Agrochemicals and Other Businesses
• In the agrochemicals business, domestic sales of the soil fumigants, TERONTM and ASAHI D-D were firm
• Sluggish overseas due to difficulties in procuring raw materials